EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals
The European Union and the United States yesterday delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
The recognition yesterday by the U.S. Food and Drug Administration (FDA) of Slovakia, the last outstanding EU Member State, marks the full implementation of the EU-U.S. Mutual Recognition Agreement (MRA) for inspections of manufacturing sites for human medicines in their respective territories. This can make it faster and less costly for both sides to bring medicines to the market.
Commissioner Vytenis Andriukaitis, in charge of Health and Food Safety yesterday said:
"The completion of the Mutual Recognition Agreement is not only a step forward in the trade relations between the EU and the U.S., but it will also ensure high quality medicines for the benefit of patients. It means that, on both sides of the Atlantic, the authorities in charge of medicines can now rely on inspections results to replace their own inspections. Today, the U.S. Food and Drug Administration has completed the capability assessments of the 28 EU competent authorities, the result of five years of close transatlantic cooperation”.
This Mutual Recognition Agreement is underpinned by robust evidence that the EU and the U.S. have comparable procedures to carry out good manufacturing practice inspections for human medicines.
Together, Europe and the United States account for more than 80% of global sales of new medicines. As a result of the full implementation of this agreement, both the industry and public authorities on both sides will be able to free resources that could be used to inspect facilities in other large producing countries.
The pharmaceutical industry is a strategic sector in which EU-U.S. regulatory cooperation is much more advanced than in most other sectors. Since May 2014, teams from the European Commission, EU national competent authorities, the European Medicines Agency (EMA) and the U.S. Food and Drug Administration have been auditing and assessing the respective supervisory systems. The U.S. Food and Drug Administration has now assessed positively all national competent authorities of the EU.
From now on, the batch testing waiver will also start to apply. This means that the qualified persons in the EU pharmaceutical company will be relieved of their task for carrying out the quality controls when carried out already in the United States.
The Mutual Recognition Agreement implementation work will continue with view to expanding the operational scope to veterinary medicines, human vaccines and plasma derived medicinal products.
In 1998, the EU and the U.S. signed a broad Mutual Recognition Agreement, which included a Pharmaceutical Annex providing for anticipated and limited reliance on each other's Good Manufacturing Practices (GMP) inspections.
2017 marked the entry into operation of the agreement between the EU and the U.S. to recognise inspections of manufacturing sites for human medicines conducted in their respective territories. This agreement strengthens reliance upon each other's inspection expertise and resources. Initially it applied between the U.S. Food and Drug Administration and those EU Member States that the U.S. Food and Drug Administration had assessed. This has been gradually extended to all EU countries and now the regulatory authorities in all 28 EU Member States were recognised by the U.S. Food and Drug Administration. Meanwhile, the EU made the same determination about U.S. Food and Drug Administration in June 2017.
Latest News from
Speech by President von der Leyen at the European Parliament Plenary on the preparation of the European Council meeting of 10-11 December25/11/2020 16:33:00
Speech given yesterday by President von der Leyen at the European Parliament Plenary on the preparation of the European Council meeting of 10-11 December
Commission adopts Action Plan on Intellectual Property to strengthen EU's economic resilience and recovery25/11/2020 15:25:00
Yesterday, the Commission published a new Action Pan on Intellectual Property to help companies, especially small and medium-sized companies (SMEs), to make the most of their inventions and creations and ensure they can benefit our economy and society.
Statement by President von der Leyen on Moderna25/11/2020 14:33:00
Statement given yesterday by President von der Leyen on Moderna.
Existing guidance appropriate for assessment of genome editing in plants25/11/2020 13:25:00
Genome editing techniques that modify the DNA of plants do not pose more hazards than conventional breeding or techniques that introduce new DNA into a plant, an EFSA assessment concludes.
Team Europe steps up delivery to its COVID-19 recovery package up to €38.5 billion for partner countries25/11/2020 12:38:00
Half of Team's Europe global recovery package to help partners address the COVID-19 pandemic, which has increased to €38.5 billion, has already been disbursed, showing the EU is delivering on its commitments.
COVID-19 and natural disasters: €823 million in EU aid for eight member states25/11/2020 11:33:00
On Tuesday, Parliament approved €823 million in EU aid for the Croatia earthquake, floods in Poland, and the response to the coronavirus crisis in seven EU countries.
EU reconfirms support for Afghanistan at 2020 Geneva Conference25/11/2020 10:38:00
The European Union yesterday reconfirmed its long-standing solidarity and partnership with the people of Afghanistan, pledging support of €1.2 billion over the period 2021–2025 in both long-term and emergency assistance at the 2020 Afghanistan Conference “Peace, Prosperity and Self-Reliance”.
EU should set goal to end homelessness by 203025/11/2020 09:25:00
On Tuesday, Parliament approved a series of recommendations to combat homelessness and end housing exclusion in the EU.
EU consumers will soon be able to defend their rights collectively24/11/2020 16:33:00
Parliament today endorsed a new law that will allow groups of consumers to join forces and launch collective action in the EU.
Remarks by Commissioner Sinkevičius, in charge of Environment, Oceans and Fisheries, at the Press Conference on the occasion of the launch of the EEA's ‘Air Quality in Europe - 2020 Report'24/11/2020 15:25:00
Remarks given by Commissioner Sinkevičius, in charge of Environment, Oceans and Fisheries, at the Press Conference on the occasion of the launch of the EEA's ‘Air Quality in Europe – 2020 Report'.